We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Protein Protects Against DNA Damage in the Developing Brain and May Act as a Tumor Suppressor

By LabMedica International staff writers
Posted on 10 May 2012
Scientists discovered that the protein TopBP1 (human DNA topoisomerase II-binding protein 1) is crucial for preventing the accumulation of DNA damage early in brain formation and in addition may serve as a tumor suppressor.

St. More...
Jude Children’s Research Hospital (Memphis, TN, USA) scientists have demonstrated that the protein TopBP1 protects early brain cells from DNA damage. Such damage might indicate later problems, including cancer.

Researchers showed that cells in the developing brain require TopBP1 to prevent DNA strands from breaking as the molecule is copied before the cell division process. Investigators also reported that stem cells and immature cells known as progenitor cells involved at the beginning of brain development are more sensitive to unrepaired DNA damage than progenitor cells later in the process. Although more developmentally advanced than stem cells, progenitor cells retain the ability to become one of a range of more specialized neurons.

“Such DNA strand breaks have great potential for creating mutations that push a normal cell toward malignancy,” said Peter McKinnon, PhD, a St. Jude department of genetics member and the article’s senior author. “When we selectively knocked out TopBP1 in mice, the amount of DNA damage we saw suggests that TopBP1 is likely to be a tumor suppressor. We are exploring that question now.”

The research appeared in the April 22, 2012, online edition of the journal Nature Neuroscience. The research builds on Dr. McKinnon’s study of DNA repair systems, including the enzymes ATM and ATR, which are associated with a devastating cancer-prone neurodegenerative disease in children called ataxia telangiectasia, and a neurodevelopmental disorder called Seckel syndrome.

TopBP1 was known to activate ATR. Earlier laboratory studies by other investigators also suggested that activation made TopBP1 invaluable for DNA replication and cell proliferation. This study, however, revealed that was not the case. Most progenitor cells in the embryonic mouse brain kept dividing after investigators inactivated the TopBP1 gene.

“We showed that rather than being fundamentally important for building the machinery of replication, TopBP1’s role is to monitor DNA damage and act when DNA damage occurs during replication,” Dr. McKinnon said. The findings provide clues into normal brain development, DNA damage repair processes, and cancer biology.

For this study, researchers monitored the impact of TopBP1 loss in progenitor cells at different stages in the developing mouse brain. The damage was most severe when the protein was knocked out in early progenitor cells. These rapidly dividing cells yield the next generations of progenitor cells that give rise to structures in the cortex involved in memory, movement, vision, and sensation. When TopBP1 was knocked out silenced in the early progenitor cells, the cortex never developed. When TopBP1 was silenced a day or two later in progenitor cells responsible for completing brain and nervous system development, the defects were present but less severe.

The progenitor cells that were created after the loss of TopBP1 were similarly full of broken strands of DNA. In both the early and later progenitor cells, unrepaired DNA damage triggered the p53 gene that activated the cell’s suicide pathway.

Researchers employed low-dose radiation to show that early progenitor cells were more sensitive to the DNA strand breaks than were progenitor cells created a day or two later. Although the cells suffered comparable damage, the damage was more apt to trigger apoptosis in the earliest progenitor cells. “This raises the likelihood that there is a different threshold to DNA damage in the early-born progenitors,” researchers noted.

Dr. McKinnon added, “These early progenitor cells give rise to the cells that go on to make various brain structures, so it is really important that there are no errors in the blueprint of these starting cells. These findings show that TopBP1 plays a critical role in maintaining the integrity of the genome.”

TopBP1 is not the only protein responsible for repairing broken DNA strands, but this study suggests it plays a unique role. When researchers turned off two other key repair factors, the proteins Lig4 and Xrcc1, in the cortex of developing mice, the loss resulted in much less severe defects than when TopBP1 was lost.

Related Links:

St. Jude Children’s Research Hospital






Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.